SEC Form 4 · accession 0001225208-18-008421
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rita A Karachun
Officer — Sr. VP Fince-Global Controller
Period of report
May 1, 2018
Accepted (ET)
May 2, 2018 · 12:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 1, 2018 | M | 3,007 | $0.00 | A | 22,205 | D | |
| Common StockF1 | May 1, 2018 | F | 1,030 | $58.87 | D | 21,175 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2 | — | May 1, 2018 | M | 3,007 | D | May 1, 2018 | May 1, 2018 | Common Stock | 3,007 | 0 | D |
Explanation of responses
- F1Holdings include shares acquired in dividend reinvestment transactions.
- F2Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.